<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Akums Drugs And Pharmaceuticals Limited — News on 6ix</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical</link>
<description>Latest news and press releases for Akums Drugs And Pharmaceuticals Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 14 May 2026 11:02:31 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/akums-drugs-and-pharmaceutical" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836484d78dffbe2df15212c.webp</url>
<title>Akums Drugs And Pharmaceuticals Limited</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical</link>
</image>
<item>
<title>Press Release May 14 2026</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-may-14-2026</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-may-14-2026</guid>
<pubDate>Thu, 14 May 2026 11:02:31 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Press Release".</description>
</item>
<item>
<title>Akums Strengthens European and UK Presence -- India's Largest CDMO Expands Global Footprint</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/akums-strengthens-european-and-uk-presence-indias-largest-cdmo-expands-global-footprint</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/akums-strengthens-european-and-uk-presence-indias-largest-cdmo-expands-global-footprint</guid>
<pubDate>Mon, 23 Feb 2026 11:29:00 GMT</pubDate>
<description>Akums Drugs & Pharmaceuticals Ltd., India's largest CDMO, has secured European Union Good Manufacturing Practice (EU GMP) certification for two of its manufacturing facilities located in India, reinforcing its growing presence in regulated global markets.</description>
</item>
<item>
<title>Press Release Feb 13 2026</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-feb-13-2026-26</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-feb-13-2026-26</guid>
<pubDate>Fri, 13 Feb 2026 22:34:12 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release".</description>
</item>
<item>
<title>Press Release Nov 13 2025</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-nov-13-2025-63</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-nov-13-2025-63</guid>
<pubDate>Thu, 13 Nov 2025 22:35:16 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Press Release".</description>
</item>
<item>
<title>Akums Receives ANVISA GMP Certification for Sterile Manufacturing Plant, Expands Global Sterile Manufacturing Footprint</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/akums-receives-anvisa-gmp-certification-for-sterile-manufacturing-plant-expands-global-sterile-manufacturing-footprint</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/akums-receives-anvisa-gmp-certification-for-sterile-manufacturing-plant-expands-global-sterile-manufacturing-footprint</guid>
<pubDate>Thu, 21 Aug 2025 12:19:00 GMT</pubDate>
<description>Delhi, India--(Newsfile Corp. - August 21, 2025) - Akums Drugs & Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), proudly announces that its Sterile Manufacturing Plant has been granted the prestigious Good Manufacturing Practices (GMP) certification by ANVISA, the Brazilian Health Regulatory Agency. This certification is a significant global milestone, enabling Akums to enhance its footprint in Brazil and other regulated markets across Latin Amer</description>
</item>
<item>
<title>Press Release Aug 08 2025</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-aug-08-2025-51</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-aug-08-2025-51</guid>
<pubDate>Fri, 08 Aug 2025 21:53:35 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 08, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release May 26 2025</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-may-26-2025-31</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-may-26-2025-31</guid>
<pubDate>Mon, 26 May 2025 23:42:48 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 26, 2025, titled "Press Release".</description>
</item>
<item>
<title>Press Release Feb 06 2025</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-feb-06-2025-44</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-feb-06-2025-44</guid>
<pubDate>Thu, 06 Feb 2025 23:23:20 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 06, 2025, titled "Press Release for December 2024 Quarter ".</description>
</item>
<item>
<title>Press Release Nov 09 2024</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-nov-09-2024-17</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-nov-09-2024-17</guid>
<pubDate>Sat, 09 Nov 2024 23:48:50 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2024, titled "Press Release".</description>
</item>
<item>
<title>Press Release Aug 24 2024</title>
<link>https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-aug-24-2024-4</link>
<guid isPermaLink="true">https://6ix.com/company/akums-drugs-and-pharmaceutical/news/press-release-aug-24-2024-4</guid>
<pubDate>Sat, 24 Aug 2024 21:56:10 GMT</pubDate>
<description>Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 24, 2024, titled "Press Release".</description>
</item>
</channel>
</rss>